Inspira Technologies’ bio-electronic patch shows 95% infection prevention

Inspira Technologies (IINN) announced positive initial results from its collaboration with Ennocure MedTech to develop a novel bio-electronic treatment for preventing bloodstream infections. In ex-vivo porcine skin model testing, the bio-electronic patch demonstrated a 95% reduction in bacterial presence within 4 hours, with continued effectiveness observed over a 24-hour period. The bio-electronic technology is being designed to address several key challenges associated with traditional IV dressings, including: prevention of bacterial growth through physical rather than chemical means, potential for extended wear time, reducing frequency of dressing changes, applicability to both skin surface and cannula areas and real-time monitoring capabilities.